Effects of Intensive Statin Therapy on Left Ventricular Function in Patients with Myocardial Infarction and Abnormal Glucose Tolerance

Cardiology
Søren AuscherKenneth Egstrup

Abstract

Abnormal glucose tolerance in patients with acute myocardial infarction (AMI) is associated with greater mortality and adverse cardiovascular effects. As statins possess a range of beneficial pleiotropic effects on the cardiovascular system, we sought to assess the cardioprotective effects of statins on left ventricular function in patients with AMI in relation to glycometabolic state. In a prospective, randomized trial, 140 patients with AMI were randomized to intensive statin therapy receiving statin loading with 80 mg of rosuvastatin followed by 40 mg daily or standard statin therapy. Patients were assessed with an oral glucose tolerance test and their left ventricular (LV) function was assessed with speckle-tracking echocardiography measuring regional longitudinal systolic strain (RLSS) in the infarct area. Overall RLSS in the infarct area improved by a mean (±SD) of -4.22% (±5.19) in the intensive-care group and -2.48% (±4.01) in the usual-care group after 1 month (p = 0.047). In patients with abnormal glucose tolerance, RLSS improved by -5.01% (±5.28) in the intensive-care group and -2.15% (±4.22) in the usual-care group (p = 0.01). Early high-dose statin treatment improved RLSS in the infarct area in patients with AMI, a...Continue Reading

References

Nov 9, 2004·Atherosclerosis. Supplements·T R PedersenUNKNOWN Scandinavian Simvastatin Survival Study Group
Aug 30, 2005·The American Journal of Cardiology·Kausik K Ray, Christopher P Cannon
May 4, 2006·JAMA : the Journal of the American Medical Association·Matthias BrielAlain J Nordmann
Jun 6, 2006·Journal of the American College of Cardiology·Benjamin M SciricaUNKNOWN PROVE IT-TIMI 22 Investigators
Jun 16, 2007·European Heart Journal·Jean-Pierre BassandWilliam Wijns
Jul 25, 2007·Journal of Internal Medicine·M BartnikL Rydén
Oct 24, 2007·European Heart Journal·Kristian ThygesenUNKNOWN Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
Mar 28, 2008·Current Hypertension Reports·Keith A Webster
Mar 26, 2009·Pharmacology & Therapeutics·Andrew LudmanDerek J Hausenloy
Oct 17, 2009·JACC. Cardiovascular Imaging·Brian B LøgstrupKenneth Egstrup
Apr 29, 2010·European Heart Journal·M Louisa AntoniJeroen J Bax
Mar 16, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Simone PostPieter A Doevendans
Feb 1, 2013·Journal of Cardiovascular Pharmacology and Therapeutics·Zhengzhong WangZhiming Ge

❮ Previous
Next ❯

Citations

Mar 5, 2018·European Journal of Pharmacology·Massa OiEugene F du Toit

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.